Bernstein Upgrades J&J (JNJ) to Outperform; Sees Pharma Pipeline Adding $6B in Sales by 2015

Go back to Bernstein Upgrades J&J (JNJ) to Outperform; Sees Pharma Pipeline Adding $6B in Sales by 2015
Johnson & Johnson (NYSE: JNJ) Delayed: 272.30 +1.19 (0.44%)
Previous Close $271.11    52 Week High $126.07 
Open $273.00    52 Week Low $94.28 
Day High $276.47    P/E 56.61 
Day Low $270.56    EPS $4.81 
Volume 3,378,564